Wire Stories
JW Therapeutics Acquires Syracuse Biopharma and License to Eureka Therapeutics� Solid Tumor Technology in China
SHANGHAI & EMERYVILLE, Calif.–(BUSINESS WIRE)–JW Therapeutics, a clinical stage biopharmaceutical company focused on developing, manufacturing and commercializing cell therapies for patients in...